Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2014 1
2015 1
2016 2
2017 3
2018 1
2019 1
2020 5
2021 6
2022 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.
García-Pérez J, Borobia AM, Pérez-Olmeda M, Portolés A, Castaño L, Campins-Artí M, Bertrán MJ, Bermejo M, Arribas JR, López A, Ascaso-Del-Rio A, Arana-Arri E, Fuentes Camps I, Vilella A, Cascajero A, García-Morales MT, Castillo de la Osa M, Pérez Ingidua C, Lora D, Jiménez-Santana P, Pino-Rosa S, Gómez de la Cámara A, De La Torre-Tarazona E, Calonge E, Cruces R, Belda-Iniesta C, Alcamí J, Frías J, Carcas AJ, Díez-Fuertes F; CombiVacS Study Group. García-Pérez J, et al. iScience. 2024 Aug 14;27(9):110728. doi: 10.1016/j.isci.2024.110728. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286494 Free PMC article.
Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.
Mir-Cros A, Moreno-Mingorance A, Martín-Gómez MT, Abad R, Bloise I, Campins M, González-Praetorius A, Gutiérrez MN, Martín-González H, Muñoz-Almagro C, Orellana MÁ, de Pablos M, Roca-Grande J, Rodrigo C, Rodríguez ME, Uriona S, Vidal MJ, Pumarola T, Larrosa MN, González-López JJ. Mir-Cros A, et al. Among authors: uriona s. Emerg Infect Dis. 2022 May;28(5):967-976. doi: 10.3201/eid2805.211958. Emerg Infect Dis. 2022. PMID: 35447067 Free PMC article.
Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine.
Martínez-Osorio J, García-García JJ, Moraga-Llop F, Díaz A, Hernández S, Solé-Ribalta A, González-Peris S, Izquierdo C, Esteva C, Codina G, Planes AM, Uriona S, Campins M, Ciruela P, Salleras L, Domínguez Á, Muñoz-Almagro C, de Sevilla MF. Martínez-Osorio J, et al. Among authors: uriona s. An Pediatr (Engl Ed). 2022 Jun;96(6):501-510. doi: 10.1016/j.anpede.2021.06.005. Epub 2021 Jul 6. An Pediatr (Engl Ed). 2022. PMID: 34238710 Free article.
Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain.
Hernández S, Moraga-Llop F, Díaz A, de Sevilla MF, Ciruela P, Muñoz-Almagro C, Codina G, Campins M, García-García JJ, Esteva C, Izquierdo C, González-Peris S, Martínez-Osorio J, Uriona S, Salleras L, Domínguez Á. Hernández S, et al. Among authors: uriona s. Emerg Infect Dis. 2020 Jun;26(6):1147-1155. doi: 10.3201/eid2606.190951. Emerg Infect Dis. 2020. PMID: 32441620 Free PMC article.
Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era.
Izquierdo C, Ciruela P, Hernández S, García-García JJ, Esteva C, Moraga-Llop F, Díaz-Conradi A, Martínez-Osorio J, Solé-Ribalta A, de Sevilla MF, González-Peris S, Codina G, Planes AM, Uriona S, Campins M, Muñoz-Almagro C, Salleras L, Domínguez A. Izquierdo C, et al. Among authors: uriona s. Epidemiol Infect. 2020 Nov 5;148:e279. doi: 10.1017/S0950268820002708. Epidemiol Infect. 2020. PMID: 33148361 Free PMC article.
[Characteristics of patients with invasive pneumococcal disease requiring admission to intensive care units].
Díaz-Conradi A, García-García JJ, González Peris S, Fernández de Sevilla M, Moraga Llop F, Ventura PS, Domínguez A; en representación del Grupo Barcino; Miembros del Grupo Barcino (Estudio de la Enfermedad Invasora Neumocócica en Cataluña); Domínguez A, Moraga Llop F, de Sevilla MF, González Peris S, Ciruela P, Campins M, Muñoz-Almagro C, Esteva C, Izquierdo C, Uriona S, Martínez Osorio J, Solé Ribalta A, Codina G, Soldevila N, Salleras Sanmartí L. Díaz-Conradi A, et al. Among authors: uriona s. An Pediatr (Engl Ed). 2021 Jan;94(1):19-27. doi: 10.1016/j.anpedi.2020.03.013. Epub 2020 Sep 29. An Pediatr (Engl Ed). 2021. PMID: 32998844 Spanish.
Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era.
Díaz-Conradi A, Hernández S, García-García JJ, Muñoz-Almagro C, Moraga-Llop F, Ciruela P, Izquierdo C, Campins M, de Sevilla MF, González-Peris S, Uriona S, Martínez-Osorio J, Solé-Ribalta A, Codina G, Esteva C, Planes AM, Soldevila N, Salleras L, Domínguez A. Díaz-Conradi A, et al. Among authors: uriona s. Pediatr Pulmonol. 2019 May;54(5):517-524. doi: 10.1002/ppul.24279. Epub 2019 Feb 19. Pediatr Pulmonol. 2019. PMID: 30784235
Vaccine Failures in Patients Properly Vaccinated with 13-Valent Pneumococcal Conjugate Vaccine in Catalonia, a Region with Low Vaccination Coverage.
Moraga-Llop F, Garcia-Garcia JJ, Díaz-Conradi A, Ciruela P, Martínez-Osorio J, González-Peris S, Hernández S, de Sevilla MF, Uriona S, Izquierdo C, Selva L, Campins M, Codina G, Batalla J, Esteva C, Domínguez À, Muñoz-Almagro C. Moraga-Llop F, et al. Among authors: uriona s. Pediatr Infect Dis J. 2016 Apr;35(4):460-3. doi: 10.1097/INF.0000000000001041. Pediatr Infect Dis J. 2016. PMID: 26658626
Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection.
Parés-Badell O, Martínez-Gómez X, Pinós L, Borras-Bermejo B, Uriona S, Otero-Romero S, Rodrigo-Pendás JÁ, Cossio-Gil Y, Agustí A, Aguilera C, Campins M. Parés-Badell O, et al. Among authors: uriona s. Vaccines (Basel). 2021 Dec 10;9(12):1463. doi: 10.3390/vaccines9121463. Vaccines (Basel). 2021. PMID: 34960209 Free PMC article.
22 results